References
- SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
- InabaHGreavesMMullighanCGAcute lymphoblastic leukaemiaLancet201338198811943195523523389
- FinchSCRadiation-induced leukemia: lessons from historyBest Pract Res Clin Haematol200720110911817336261
- BjörkJJohanssonBBrobergKAlbinMSmoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control studyLeuk Res200933678879119019430
- LichtmanMAObesity and the risk for a hematological malignancy: leukemia, lymphoma, or myelomaOncologist201015101083110120930095
- MullighanCGGenetic variation and the risk of acute lymphoblastic leukemiaLeuk Res201034101269127020538337
- SherborneALHoskingFJPrasadRBVariation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia riskNat Genet201042649249420453839
- WangYChenJLiJAssociation of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese populationGene2013524220320723608171
- SpeedyHEDi BernardoMCSavaGPA genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemiaNat Genet2014461566024292274
- SchinkelAHThe physiological function of drug-transporting P-glycoproteinsSemin Cancer Biol1997831611709441946
- SunJHeZGChengGWangSJHaoXHZouMJMultidrug resistance P-glycoprotein: crucial significance in drug disposition and interactionMed Sci Monit2004101RA5RA1414704647
- HodgesLMMarkovaSMChinnLWVery important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Pharmacogenet Genomics201121315216120216335
- BreierABarancíkMSulováZUhrikBP-glycoprotein – implications of metabolism of neoplastic cells and cancer therapyCurr Cancer Drug Targets20055645746816178819
- HoffmeyerSBurkOvon RichterOFunctional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProc Natl Acad Sci U S A20009773473347810716719
- KurataYIeiriIKimuraMRole of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoproteinClin Pharmacol Ther200272220921912189368
- LambaJStromSVenkataramananRMDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotypeClin Pharmacol Ther200679432533816580901
- MarzoliniCPausEBuclinTKimRBPolymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevanceClin Pharmacol Ther2004751133314749689
- Brambila-TapiaAJMDR1 (ABCB1) polymorphisms: functional effects and clinical implicationsRev Invest Clin201365544545424687344
- BaldisseraVDde MattosAACoralGPEvaluation of the C3435T polymorphism in the MDR1 gene in patients with hepatocellular carcinomaAnn Hepatol201211689990623109454
- WangZWangTBianJAssociation between MDR1 C3435T polymorphism and risk of breast cancerGene20135321949924070710
- KimHNKimNYYuLPolymorphisms in DNA repair genes and MDR1 and the risk for non-Hodgkin lymphomaInt J Mol Sci20141546703671624756092
- JamroziakKMłynarskiWBalcerczakEFunctional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemiaEur J Haematol200472531432115059065
- JamroziakKBalcerczakECebulaBJanusAMirowskiMRobakTNo influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cellsTher Drug Monit200628570771117038891
- JamroziakKBalcerczakESmolewskiPMDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemiaPharmacol Rep200658572072817085864
- HattoriHSuminoeAWadaMRegulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemiaLeuk Res200731121633164017568669
- UrayamaKYWienckeJKBufflerPAChokkalingamAPMetayerCWiemelsJLMDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemiaCancer Epidemiol Biomarkers Prev20071661172117717548681
- Leal-UgarteEGutiérrez-AnguloMMacías-GómezNMMDR1 C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individualsHum Biol200880444945519317599
- LiuRRThe role of multidrug resistance gene 1 polymorphism to prognosis of adult acute lymphoblastic leukemia patientsCentral South University20085148
- SemseiAFErdélyiDJUngváriIAssociation of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemiaLeuk Res20083281214122018243305
- RochaVPorcherRFernandesJFAssociation of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemiaLeukemia200923354555619005482
- RaoDNAnuradhaCVishnupriyaSAssociation of an MDR1 gene (C3435T) polymorphism with acute leukemia in IndiaAsian Pac J Cancer Prev20101141063106621133625
- PennaGAllegraAAlonciAMDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosisMed Oncol20112841549155420496015
- Bektaş-KayhanKKüçükhüseyinÖKaragözGIs the MDR1 C3435T polymorphism responsible for oral mucositis in children with acute lymphoblastic leukemia?Asian Pac J Cancer Prev201213105251525523244145
- LüHDuZZWangWRelationship between genetic polymorphism of multidrug resistance 1 gene and the risk of childhood acute lymphocytic leukemiaZhonghua Er Ke Za Zhi2012509692696 Chinese23158821
- GréenHFalkIJLotfiKAssociation of ABCB1 polymorphisms with survival and in vitro cytotoxicity in de novo acute myeloid leukemia with normal karyotypePharmacogenomics J201212211111820938465
- SinghOChanJYLinKHengCCChowbayBSLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemiaPLoS One2012712e5177123272163
- VivonaDBuenoCTLimaLTABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinibBlood Cells Mol Dis201248213213622134106
- ZhaiXWangHZhuXGene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemiaArch Med Sci20128465967123056078
- SongPLambaJKZhangLG2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expressionJ Clin Pharmacol200646337337916490813
- Kimchi-SarfatyCOhJMKimIWA “silent” polymorphism in the MDR1 gene changes substrate specificityScience2007315581152552817185560
- TeraoTHisanagaESaiYTamaiITsujiAActive secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrierJ Pharm Pharmacol19964810108310898953513
- TanigawaraYRole of P-glycoprotein in drug dispositionTher Drug Monit200022113714010688277
- ElliottJIRaguzSHigginsCFMultidrug transporter activity in lymphocytesBr J Pharmacol2004143789990715492020
- PawlikABaskiewicz-MasiukMMachalinskiBKurzawskiMGawronska-SzklarzBInvolvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasoneEur J Pharmacol20055281–3273616321374
- QianXCaoSYangGVariant genotypes of MDR1 C3435T increase the risk of leukemia: evidence from 10 case-control studiesLeuk Lymphoma20125361183118722088099